The Perl Toolchain Summit needs more sponsors. If your company depends on Perl, please support this very important event.
   [1]The Journal of Biological Chemistry

   [2]Skip to main page content
     * [3]Home
     * [4]Current issue
     * [5]Archive
     * [6]Papers in Press
     * [7]Minireviews
     * [8]Classics
     * [9]Reflections
     * [10]Papers of the Week

   QUICK SEARCHAuthor: _________Keyword: ________________Year: ____Vol:
   ____Page: ____ GO Go[11][Advanced Search][12][Browse the Archive]
     * Institution: Univ Colorado - Denison Memorial Library
     * [13]Sign In

   Advertisement
   Advertisement
     * [14]Celebrate 100 Years of ASBMB: ASBMB Histroy Book Now Avaiable!

 §1§ The ι-Carrageenase of Alteromonas fortis §1§

 §2§ A β-HELIX FOLD-CONTAINING ENZYME FOR THE DEGRADATION OF A HIGHLY
POLYANIONIC POLYSACCHARIDE[15]* §2§

    1. [16]Gurvan Michel[17]‡[18]§,
    2. [19]Laurent Chantalat[20]‡,
    3. [21]Eric Fanchon[22]‡,
    4. [23]Bernard Henrissat[24]¶,
    5. [25]Bernard Kloareg[26]§ and
    6. [27]Otto Dideberg[28]‡[29]‖

    1.


    From the ^‡Laboratoire de Cristallographie Macromoléculaire, Institut
    de Biologie Structurale Jean-Pierre Ebel, CNRS/Commissariat Å
    l'Energie Atomique, 41, rue Jules Horowitz, 38027 Grenoble Cedex 1,
    France, the ^§Station Biologique de Roscoff, UMR 1931 (CNRS and
    Laboratoires Goëmar), Place Georges Teissier, BP 74, 29682 Roscoff
    Cedex, France, and the ^¶Architecture et Fonction des Macromolécules
    Biologiques, UMR 6098 (CNRS, Universités d'Aix-Marseille I et II), 31
    Chemin Joseph Aiguier, 13402 Marseille Cedex 20, France


   [30]Next Section

 §2§ Abstract §2§

   Carrageenans are gel-forming hydrocolloids extracted from the cell
   walls of marine red algae. They consist ofd-galactose residues bound by
   alternate α(1→3) and β(1→4) linkages and substituted by one
   (κ-carrageenan), two (ι-carrageenan), or three (λ-carrageenan)
   sulfate-ester groups per disaccharide repeating unit. Both the κ- and
   ι-carrageenan chains adopt ordered conformations leading to the
   formation of highly ordered aggregates of double-stranded helices.
   Several κ-carrageenases and ι-carrageenases have been cloned from
   marine bacteria. κ-Carrageenases belong to family 16 of the glycoside
   hydrolases, which essentially encompasses polysaccharidases specialized
   in the hydrolysis of the neutral polysaccharides such as agarose,
   laminarin, lichenan, and xyloglucan. In contrast, ι-carrageenases
   constitute a novel glycoside hydrolase structural family. We report
   here the crystal structure of Alteromonas fortisι-carrageenase at 1.6 Å
   resolution. The enzyme folds into a right-handed parallel β-helix of 10
   complete turns with two additional C-terminal domains. Glu^245,
   Asp^247, or Glu^310, in the cleft of the enzyme, are proposed as
   candidate catalytic residues. The protein contains one sodium and one
   chloride binding site and three calcium binding sites shown to be
   involved in stabilizing the enzyme structure.

   Carrageenans are the main components of the cell walls of various
   marine red algae (Rhodophyta) where they play a variety of structural
   (cell-cell cohesion and exchange boundary) and signaling (cell-cell
   recognition) roles ([31]1, [32]2). They consist of linear chains of
   galactopyranose residues in the d-configuration linked by alternating
   α(1→3) and β(1→4) linkages. This regular structure is modified by
   3,6-anhydro bridges and substitution with sulfate-ester groups. On the
   basis of the level and position of sulfate substitution, carrageenans
   are classified into four types, namely furcellaran and κ-, ι-, and
   λ-carrageenans. κ-Carrageenan consists of repeated units of the
   disaccharide
   4-sulfate-O-1,3-β-d-galactopyranosyl-1,4-α-3,6-anhydro-d-galactose,
   also known as neocarrabiose sulfate. At the primary structure level,
   ι-carrageenan differs from κ-carrageenan in the presence at C-2 on the
   α-linked galactose residues of one additional sulfate substituent per
   repeating disaccharide (Fig.[33]1). ι-Carrageenans therefore contain
   two sulfate groups per repeat unit, i.e. one anionic group per
   monosaccharide. Such a high linear charge density is reminiscent of
   that seen in alginic acid, the main cell wall polysaccharide of brown
   algae, and in polygalacturonic acid, the nonmethylated component of
   higher plant pectins, which both contain one carboxyl group per
   monomeric unit ([34]1).
   [35]Figure 1
   View larger version:
     * [36]In this window
     * [37]In a new window

     * [38]Download as PowerPoint Slide

   Figure 1

   Schematic diagram showing two disaccharide repeating units of
   ι-carrageenan. The two different glycosidic bonds in ι-carrageenan are
   labeled, and further extensions of the polymer at the nonreducing and
   reducing ends are indicated, respectively, by R′ and R". As
   ι-carrageenase cleaves the β(1→4) glycosidic bond, its subsites for
   substrate binding are labeled in accordance with the established
   nomenclature ([39]49).

   In aqueous solution, κ- and ι-carrageenans form thermoreversible gels
   ([40]3) and are used in a variety of industrial applications as gelling
   or thickening agents. The mechanism of gelation involves the formation
   of double helices of carrageenan chains followed by the association of
   the double helices into a macromolecular three-dimensional network
   ([41]4, [42]5). Gelation is promoted by the presence of cations,
   potassium in κ-carrageenan and calcium in ι-carrageenan. By binding to
   the helices, either electrostatically or through specific binding
   sites, these cations considerably reduce the charge density of the
   helices and enhance their tendency to aggregate ([43]6). The fine
   structure of ι-carrageenan in the solid state has been studied in
   detail by x-ray diffraction of calcium carrageenate fibers ([44]7). The
   polysaccharide chains were shown to adopt a twisted-ribbon conformation
   with a 3[1] symmetry, stabilized by the formation of double helices,
   themselves aggregated into larger clusters through the coordinated
   binding of calcium ions ([45]7). In the cell walls of red algae,
   carrageenans are laid out as highly ordered molecules associated with
   the cellulose microfibrils or in the microfibril-less intercellular
   matrix ([46]8). ι-Carrageenans are mainly located in the outer cortical
   tissues, whereas κ-carrageenans constitute the walls of the inner
   cortical and medullary cells ([47]9).

   Enzymes that degrade carrageenans, namely κ-, ι-, and λ-carrageenases,
   have been isolated from various marine bacteria. They all are
   endohydrolases that cleave the internal β(1→4) linkages of carrageenans
   yielding products of the neocarrabiose series ([48]10-13). Since these
   galactan hydrolases display a strict substrate specificity, they
   obviously recognize the sulfation pattern on the digalactose repeating
   unit and thus provide an opportunity for investigating the
   structure-function relationships of hydrolases that degrade sulfated
   polysaccharides. With this aim, we have undertaken the structural
   analysis of a representative set of carrageenases. Recently we reported
   the deduced amino acid sequences of ι-carrageenase fromAlteromonas
   fortis and Zobellia galactanovorans. They share no sequence similarity
   with κ-carrageenases, and unlike β-agarases and κ-carrageenases, they
   are inverting hydrolases. They represent the first members of a new
   family of glycoside hydrolases ([49]14), family 82 (13). In this
   context, a high-resolution three-dimensional structure for a
   ι-carrageenase would be pivotal in determining the fold prevailing in
   family 82 and in delineating the molecular bases for the recognition of
   ι-carrageenan. To this end, we have recently overexpressed and
   crystallized A. fortisι-carrageenase ([50]15), and we report here its
   structure at 1.6 Å resolution.
   [51]Previous Section[52]Next Section

 §2§ EXPERIMENTAL PROCEDURES §2§

 §5§ Expression, Purification, and Crystallization of Native and
Selenomethionyl-ι-carrageenase §5§

   Full details of the expression and purification of native
   ι-carrageenase have been described previously ([53]15). Briefly,
   ι-carrageenase was expressed using the pET20b vector ([54]Novagen) as a
   His-tagged fusion protein in the periplasm of Escherichia coli
   BL21(DE3) strain and purified by metal affinity chromatography on a
   column of Chelating Fast Flow Sepharose (Amersham Pharmacia Biotech)
   loaded with NiSO[4]. The yield was 7–8 mg/liter of culture medium, and
   the purified protein was concentrated to 6 mg/ml using a dialyzing
   concentrator (Amicon Co.). Single crystals were obtained with
   polyethylene glycol, and the presence of calcium ions appeared to be
   crucial for crystallization. High quality crystals, typically 0.25 ×
   0.25 × 0.15 mm in dimensions, were grown with 0.1 m sodium cacodylate
   at pH 6.5, 15–17% polyethylene glycol (M [r] = 6,000), and 200 mm
   calcium acetate.

   The seleno-l-methionine labeling procedure was identical to that
   described for the expression of seleno-l-methionine
   (Se-Met)^1-κ-carrageenase ([55]16). As the expression yield was only
   800 μg/liter of culture medium, the volume had to be scaled up to
   obtain a sufficient amount of protein. During the concentration step,
   the Se-Met-ι-carrageenase appeared to be less soluble than the native
   protein and could only be concentrated to 2 mg/ml. Crystallization of
   Se-Met-ι-carrageenase was performed under similar conditions to those
   already reported ([56]15) except for the addition of 1 mm
   dithiothreitol and the replacement of sodium cacodylate by imidazole to
   avoid the reaction between cacodylate and dithiothreitol ([57]17).
   Under these conditions, small crystals with a maximal size of 100 × 100
   × 50 μm were obtained in 1 month of equilibration, whereas large native
   crystals appeared in a few days.

 §5§ Data Collection and Processing §5§

   Crystals were successively soaked for 30 s in crystallization solutions
   in which the glycerol concentration was increased by steps of 5% to a
   final concentration of 20%. A single crystal was mounted on a loop,
   transferred to the goniometer head, and kept at 100 K in a nitrogen
   stream. The multiple anomalous diffraction data were collected on a
   Se-Met-ι-carrageenase crystal at three wavelengths around the K (λ =
   0.9t95 Å) absorption edge of selenium (beamline FIP/BM 30, European
   Synchrotron Radiation Facility (ESRF), Grenoble, France). A 345-mm
   Marresearch image plate detector was used. All intensity data were
   integrated and reduced using DENZO/SCALEPACK ([58]18). Based on unit
   cell dimensions two molecules of protein are present in the asymmetric
   unit. Using the Patterson method and SHELX 97 (19), the positions for 7
   of the 16 selenium atoms expected were determined. This partial
   structure was input into SHARP ([59]20) for a first approximation of
   the phases. Five other selenium atoms were located in the Fourier
   difference electron density map. The final partial structure therefore
   contained 12 selenium atoms, and the final phases from SHARP resulted
   in a figure of merit of 0.43–2.3 Å resolution. Low (up to 2.2 Å) and
   high (up to 1.6 Å) resolution data were also collected on a native
   ι-carrageenase crystal using a Marresearch charge-coupled device
   detector (beamline ID14 EH2, ESRF). All intensity data were integrated
   using DENZO ([60]18). At low temperature, the unit cell parameters were
   slightly different: a = 55.87, b = 90.07, c = 124.12 Å, α = γ = 90°, β
   = 93.53°. The low and high resolution data were merged and reduced with
   SCALA ([61]21).

 §5§ Structure Determination and Refinement §5§

   Taking advantage of the noncrystallographic symmetry, the electron
   density was improved by molecular averaging, histogram matching, and
   solvent flattening (50% solvent) with DM ([62]21). Using the native
   data, the phases were then extended to 1.6 Å resolution yielding a
   figure of merit of 0.75. Due to the high quality of the electron
   density map at 1.6 Å, wARP ([63]22) was used to build the model
   automatically resulting in the assignment of 85 and 75% of the main and
   side chain atoms, respectively. The rest of the model was built
   manually using O ([64]23). However, no clear electronic density was
   observed for residues 314–333 and 341–350, which are not included in
   the final model. The refinement was performed with CNS ([65]24) using
   the native data set to 1.6 Å with the maximum likelihood target
   function. The program was set up to automatically compute a
   cross-validated ς[a] estimate and the weighting scheme between the
   x-ray refinement target and the geometric energy function. Corrections
   for a flat bulk solvent and for anisotropy in the data were also
   applied. The ς[a] weighted maps obtained from the subsequent refinement
   models were used for further model building. The first group of water
   molecules was added when peaks in the 2F [o] −F [c] density were >2 ς
   and had a stereochemistry compatible with at least one hydrogen bond
   with a protein atom or another water molecule. In the final stages, the
   ς cut-off was reduced to 1.0 ς, and water molecules with a B factor >60
   Å^2 were removed from the model. The final model refined at 1.6 Å has
   an R[work] of 20.7% and an R[free] of 22.3% ([66]25) and consists of
   6,840 protein atoms, 1,110 water molecules, six glycerol molecules, and
   six calcium, six sodium, and two chloride ions. All these ions have an
   occupancy of 1, and their B factors refine to a value close to
   neighboring protein atom B factors. The stereochemistry of the final
   structure was evaluated using the PROCHECK program ([67]26).

 §5§ Calcium-dependent Activity Test and Proteolytic Digestion §5§

   ι-Carrageenase activity was assayed as follows. Three enzyme solutions
   were prepared by diluting a stock solution of the purified enzyme (6
   mg/ml) in 100 mm Tris-HCl, pH 7.2, 200 mm NaCl and adding either 5 mm
   EGTA or 5 mm CaCl[2]. Aliquots (100 μl) were incubated for 15 min at
   40 °C with 2 ml of substrate solution consisting of 0.125% (w/v)
   ι-carrageenan, 50 mm Tris-HCl, pH 7.2, 100 mm NaCl with or without 5 mm
   CaCl[2], and the reaction mixture (200 μl) was assayed for reducing
   sugars ([68]27) using boiled enzyme blanks. One unit of enzyme activity
   is defined as the amount of enzyme that produces an increase of 0.1 A
   [237 nm]/min in the reducing sugar assay.

   Purified bovine pancreas trypsin (T1426, 10,000N-benzoyl-l-arginine
   ethyl ester units/mg of protein) was purchased from Sigma. Limited
   proteolysis of ι-carrageenase (6 mg/ml in 100 mm Tris-HCl, pH 7.2, 200
   mm NaCl) was performed using trypsin/ι-carrageenase ratios of 1:100 and
   1:20 (w/w) in the presence or absence of 5 mm EGTA or 5 mm CaCl[2]. The
   samples were incubated for 1 h at 20 °C, and then the reaction was
   stopped by adding SDS loading buffer and boiling the samples for 5 min
   at 100 °C. The samples were then loaded onto a 15% SDS-polyacrylamide
   gel for electrophoresis, and the gels were stained with Coomassie Blue.
   [69]Previous Section[70]Next Section

 §2§ RESULTS §2§

 §5§ The Overall Structure of A. fortis ι-Carrageenase §5§

   The three-dimensional crystal structure of ι-carrageenase lacking the
   signal peptide (residues 1–27) was determined at 2.3 Å resolution by
   the multiple anomalous diffraction method using a crystal of a
   Se-Met-substituted form of the enzyme ([71]28). After phase extension
   with a native data set at higher resolution, a high quality electron
   density map was obtained (Fig. [72]2) allowing building and refinement
   of the model at 1.6 Å resolution. The crystallographic statistics are
   shown in Table [73]I. The asymmetric unit contains two mature
   ι-carrageenase molecules, each containing amino acids 28–491. Residues
   314–334 and 341–350 for molecule A and residues 313–334 and 341–351 for
   molecule B are not visible in the 2F [o] − F [c] electron density map
   and are presumed to exist in disordered or highly flexible
   conformations. Superposition of molecules A and B reveals that the Cα
   atoms overlay with a root mean square deviation of 0.21 Å.
   Approximately 10 residues in each molecule presented clear alternate
   conformations. The need to refine the occupancy for terminal atoms of
   several residues, such as aspartate, glutamate, or methionine, suggests
   that a fraction of the protein population in the crystal has been
   subjected to radiation damage ([74]29).
   [75]Figure 2
   View larger version:
     * [76]In this window
     * [77]In a new window

     * [78]Download as PowerPoint Slide

   Figure 2

   Solvent-flattened multiple anomalous diffraction electron density map
   at 1.6 Å resolution. Map contoured at 2.0 ς of the N-terminal
   calcium-binding hairpin loop. Calcium ion and water molecules are
   indicated as yellow andred spheres, respectively. The oxygen, nitrogen,
   and carbon atoms in the protein are shown in red, blue, andyellow,
   respectively. This figure was created using O ([79]23).
   View this table:
     * [80]In this window
     * [81]In a new window

   Table I

   Data reduction, phasing, and refinement statistics

   The core of ι-carrageenase is folded into a right-handed parallel
   β-helix of 10 complete turns (Fig. [82]3). This fold was first
   encountered in pectate lyase C from Erwinia chrysanthemi ([83]30). The
   lyase structure consists of three parallel β-sheets, PB1, PB2, and PB3.
   PB2 and PB3 form planar surfaces almost perpendicular to each other,
   while PB1 is in the form of a groove. In the lyase structure, the turns
   or loops (depending on the number of amino acids inserted between
   consecutive β-helical strands) are referred to as T1 (PB1-PB2), T2
   (PB2-PB3), and T3 (PB3-PB1). In β-helix proteins, the assignment of
   secondary structure elements is based on the DSSP algorithm ([84]31)
   with the additional criterion that any residues with (Φ, ψ) angles in
   the left-handed α-helix region are not included in the β-strand. Based
   on these rules, PB2 can be divided into two parts, and the
   ι-carrageenase β-helix consists of four parallel β-sheets, PB1, PB2a,
   PB2b, and PB3, composed respectively of 10, 5, 11, and 10 β-strands.
   These strands are relatively short with an average number of 4.0, 2.4,
   4.1, and 4.0 residues, respectively. Interestingly, like almost all
   β-helix proteins, ι-carrageenase contains in its N-terminal region an
   amphipathic α-helix (residues 66–77) that shields the hydrophobic core
   of the β-helix from the solvent.
   [85]Figure 3
   View larger version:
     * [86]In this window
     * [87]In a new window

     * [88]Download as PowerPoint Slide

   Figure 3

   Folding of A. fortisι-carrageenase. A, stereo view of the Cα trace of
   the protein. The N terminus, C terminus, and every 20th residue are
   labeled, while every 10th residue is marked with ablack dot. The
   secondary structures listed in the text are composed of the following
   residues: β15, 187–189; β18, 200–204; β25, 240–245; β26, 258–260; β28,
   267–270; β32, 302–304; β35, 378–381; β36, 383–386; β39, 434–436. B,
   ribbon representation of the structure. The β-helix core, domain A, and
   domain B are shown, respectively, in blue, gold, and red. The small T1
   extension, containing an antiparallel sheet (β16-β17) and an α-helix
   (α2), is shown ingreen. The red, yellow, andgreen spheres represent
   sodium, calcium, and chloride ions, respectively. Figs. [89]3 and [90]4
   were prepared using Molscript ([91]50).

   The most striking difference between ι-carrageenase (Fig. [92]3) and
   the 11 other β-helix proteins of known structure is the presence, in
   the C-terminal region, of two large additional domains (both 67
   residues long). Domain A (residues 307–373) replaces the T1 turn
   between strands β32 and β35 (see legend of Fig. [93]3 A for
   definition). Half of this domain (residues 314–333 and 341–350) could
   not be built as no clear electron density was observed. The visible
   part of domain A features a sheet of two short antiparallel β-strands,
   β33 and β34, edged by one α-helix (residues 358–367) and has an average
   B value (37.8 Å^2) twice that of the β-helix core (17.8 Å^2). At the
   border of the visible part of domain A is a hydrophobic surface,
   suggesting that the nonvisible residues complete a globular-shaped
   domain. This domain is weakly bound to the β-helix by only four
   hydrogen bonds (Glu^310 O-Lys^252 NZ, Asp^358OD1-Ser^442 OG, Asp^358
   OD2-Lys^443 N, and Asp^362 OD1-Tyr^444 OH). Moreover, the visible part
   of domain A makes no contact with neighboring molecules and is located
   in a large solvent channel in the crystal. Domain B consists of
   residues 387–430, located on a T3 turn that connect strands β36 and
   β39, and the C-terminal extension (residues 469–491). Mainly composed
   of long loops, it also features an antiparallel β-sheet (β37-β38), a
   3[10] helix (residues 395–402), and a one-turn α-helix at the C
   terminus. This domain, also globular in shape, is folded around an
   independent hydrophobic core. In contrast to domain A, this bulky
   structure is characterized by many side chain-side chain and side
   chain-main chain hydrogen bonds, both within the domain and with the
   β-helix. These hydrogen bonds have a clear stabilizing effect on domain
   B since its average B value (22.0 Å^2) is close to that of the β-helix
   core (17.8 Å^2).

   Each strand of PB2a is connected to PB2b by an asparagine residue in a
   left-handed α-helix conformation. Residues in the α[L]conformation are
   also seen in the T2 turns in the structure. The presence of these
   residues results in sharp bends of about 100° in the polypeptide chain
   without disrupting the hydrogen bond pattern of the parallel β-strands.
   PB1 also presents a striking repetition of a structural irregularity:
   in each strand, one residue is in a right-handed helix conformation,
   thus creating an alignment of nine β-bulges in the groove. With the
   exceptions of Ser^186 and the Lys^464-Thr^465 β-bulge in the C
   terminus, which are accessible to the solvent, all side chains in these
   β-bulges are aliphatic amino acid residues and point toward the
   hydrophobic core of the β-helix.

   The turns and loops between the β-strands are of different sizes and
   have different conformations. Whereas almost all of the T2 turns
   consist of a single residue in the α[L] conformation, the T1 and T3
   turns are longer and more irregular, their sizes ranging from 1 to 12
   and from 2 to 8 residues, respectively. At the N-terminal edge of the
   β-helix, the T3 loops form a bulky protrusion above PB1. On the
   opposite side of this β-sheet, the T1 turn between strands β15 and β18
   folds into a β-sheet of two antiparallel strands (β16 and β17), and the
   T1 turn between β25 and β26 folds into a short α-helix. Strands β16 and
   β17 and this short α-helix form a domain that is stabilized by a
   hydrophobic core (Val^191, Leu^198, Leu^250, Met^251, and Tyr^254) and
   hydrogen bonds between Glu^193OE2-Tyr^254 OH and Leu^198 O-Gln^256OE1.
   At the surface, two hydrophilic networks (Arg^136-Asp^166-Arg^194 and
   Arg^202-Trp^200-Asp^227-Arg^260-Gly^257-Gly^258) firmly bind this
   domain to the β-helix core; these amino acids are also present in Z.
   galactanovorans ι-carrageenase. On each edge of β-sheet PB1, the
   N-terminal T1 and T3 extensions and the protruding domains A and B in
   the C-terminal region create a long deep cleft. This large channel,
   about 50 Å long and 10 Å wide, is probably the cleft that binds
   ι-carrageenan chains.

   A. fortis ι-carrageenase contains four disulfide bridges. The first,
   Cys^269-Cys^298, is located within the β-helix core, connecting strand
   β28 to the T3 turn between strands β31 and β32. The Cys^336-Cys^360
   bridge, which links the 334–340 loop to helix α3, probably stabilizes
   domain A. This disulfide bridge was opened by radiation damage, but its
   existence was confirmed by the refinement of the structure (data not
   shown) from the data at 2.0 Å resolution obtained with a less powerful
   beamline ([94]15). However, even in this latter electron density map
   with an intact disulfide bridge, the above-mentioned nonvisible part of
   domain A could not be seen either. The two other disulfide bridges,
   Cys^408-Cys^476 and Cys^412-Cys^484, which are strictly conserved in
   the two ι-carrageenase sequences, bring the C-terminal extension of the
   protein into close proximity with the main part of domain B. Finally,
   the ι-carrageenase structure contains two chloride, six sodium, and six
   calcium binding sites (see below).

   A major characteristic of β-helix proteins is their internal stability
   (mean B factor of 15.6 Å^2), which results from numerous intrahydrogen
   bonds and side chain stacking of identical or similar residues
   ([95]32). Consistent with these observations, the ι-carrageenase
   structure is dominated by aliphatic stacking in the β-helix interior.
   Four major stacks (Ile^209-Leu^234-Ile^267-Val^293-Val^383-Val^453,
   Ile^229-Ile^262-Val^288-Val^378,
   Ile^187-Ile^221-Leu^242-Val^276-Val^302-Val^434, and
   Ile^113-Val^149-Ile^117) form the hydrophobic core, but short stacks
   (Val^290-Val^380, Val^135-Val^167, Ile^187-Ile^221, Ile^172, and
   Ile^206) also strengthen the β-helix cohesion. In the aligned β-bulges,
   stacking of alanine residues (Ala^241-Ala^275-Ala^301-Ala^433), all in
   the α[R] conformation, is also seen. In contrast to pectate lyases,
   however, clusters of aromatic residues are of minor importance,
   involving only short clusters (Phe^381-Phe^451, Phe^147-Phe^175,
   Phe^127-Phe^162, Phe^184-Tyr^218). On the surface of the protein, two
   rows of asparagine residues in the α[L] conformation
   (Asn^102-Asn^137-Asn^169-Asn^203-Asn^228-Asn^261and
   Asn^233-Asn^266-Asn^293) flank β-sheet PB2, but few of these amino
   acids are engaged in successive hydrogen bonds, and only a short
   portion of asparagine ladder (Asn^102-Asn^137-Asn^163) can be
   identified. In contrast, as in Flavobactrium heparinumchondroitin lyase
   B ([96]33), the ι-carrageenase β-helix features external basic stacks,
   which consist of a short lysine pair (Lys^373-Lys^449) and a cluster of
   arginines (Arg^136-Arg^168-Arg^202-Arg^260).

 §5§ ι-Carrageenase Contains Binding Sites for Sodium, Chloride, and
Calcium §5§

   The structure of ι-carrageenase reveals six sodium, two chloride, and
   six calcium ion binding sites. Four of the sodium ions are located at
   the interface between molecules A and B in the asymmetric unit and form
   two clusters related by the noncrystallographic symmetry. In one
   cluster, sodium ions are bound to a carboxyl group, Asp^54 or Glu^108,
   and to four water molecules, three of which are shared by the ions.
   Since ι-carrageenase elutes as a monomer on gel filtration (data not
   shown), the presence of these four sodium binding sites is probably due
   to crystal packing. The last two sodium binding sites are located in
   the same region of molecules A and B in the interior of the β-helix
   core, 14–15 Å from the catalytic residues. In one molecule, the sodium
   ion is coordinated by five ligands with a trigonal bipyramidal geometry
   and at an average distance of 2.35 Å; these ligands are the oxygens of
   Leu^159, Ile^183, and Phe^184, the hydroxyl of Thr^182, and one water
   molecule. Thr^182, Ile^183, and Phe^184 are conserved in Z.
   galactanovoransι-carrageenase ([97]13). Interestingly, Phe^184 adopts a
   disallowed conformation (φ = 78, ψ = 139). Each protein molecule binds
   one chloride ion, which is located on the surface of the groove,
   slightly buried in a hydrophobic pocket and 7 Å from both the
   above-mentioned sodium ion and the catalytic residues. This hydrophobic
   cavity is composed of the conserved residues Phe^184, Ala^185, Leu^188,
   and Tyr^284. The chloride ion is also in contact with the amide group
   of the conserved Gln^222, the backbone amino group of Ala^185, and one
   water molecule. The activity of ι-carrageenase is known to depend on
   the presence of sodium chloride and to decrease rapidly on either side
   of the optimum concentration of 100 mm NaCl; complete salt removal or
   NaCl concentrations higher than 500 mmresult in complete loss of
   activity ([98]34). However, how the presence of sodium and chloride
   binding sites in ι-carrageenase accounts for its activation by sodium
   chloride remains an open question.

   Interestingly, each ι-carrageenase molecule also has three calcium ion
   binding sites, all remote from the active site. The first is located at
   the surface between the second and third T2 turns. The calcium ion
   makes hydrogen bonds with the backbone oxygen and hydroxyl group of
   Ser^109, the side chain carbonyl of Asn^145, the oxygen of Gly^146, and
   four water molecules. As these ligands are not present in Z.
   galactanovorans ι-carrageenase ([99]13) this site appears to be
   specific to A. fortis ι-carrageenase. The second and third sites, which
   display a hairpin topology, are well conserved between the two
   ι-carrageenases. The second site precedes the N-terminal α-helical cap
   (Fig. [100]2). The calcium ion, buried inside the hairpin loop,
   establishes short contacts (average distance 2.37 Å) with Asn^58 O,
   Asp^61 OD1, Ser^63 O, Asp^65 OD1 and OD2, and two water molecules.
   Asn^58, Asp^61, and Asp^65 are strictly conserved in the two
   ι-carrageenases. The hairpin loop is also structured and anchored to
   the β-helix by numerous hydrogen bonds (Asn^58 OD1-Asn^60 N,
   Gly^59O-Thr^91 N, Asp^61 OD1-Ser^63 N, Asp^64 OD1-Asp^65 N-Ser^66 N and
   OH, Asp^65 OD1-Asn^58 N, and Asp^65OD2-His^93 N). The third calcium
   binding site is in a more complex and irregular hairpin loop in the
   C-terminal region. It is in interaction with Thr^438 OH, Asp^445 OD1,
   Asp^445 OD2, Asp^447 OD1, and one water molecule. This site is
   strengthened by Asp^436, which makes a hydrogen bond with Thr^438 OH
   and the above-mentioned water molecule. Only Asp^436 and Thr^438 are
   strictly conserved in the two enzymes, while Asp^445 and Asp^447 are
   replaced by asparagine residues in Z. galactanovoraι-carrageenase.

   The potential influence of calcium ions on the stability of
   ι-carrageenase was tested. Compared with the activity in the
   purification buffer (10 mm Tris-HCl, pH 7.2, 200 mm NaCl), the addition
   of either 5 mmCaCl[2] or 5 mm EGTA had no effect on ι-carrageenase
   activity. In contrast, the trypsin digestion pattern of ι-carrageenase
   was clearly affected by the presence of either EGTA or CaCl[2] (Fig.
   [101]4). In the control buffer, trypsin digestion of ι-carrageenase
   (1:100 w/w) resulted in the release of several peptides with sizes
   ranging from 5 to 53 kDa, but most of the protein was undegraded; under
   the same conditions, this pattern was not affected by the presence of 5
   mm EGTA. A trypsin/ι-carrageenase ratio of 1:20 resulted in greater
   protein degradation especially in the presence of EGTA when the protein
   was almost completely degraded. In contrast, at either
   trypsin/ι-carrageenase ratio, the addition of 5 mmCaCl[2] significantly
   protected ι-carrageenase from proteolysis. Although the enzyme was
   purified in the absence of calcium, the marked differences seen in the
   digestion patterns in the presence or absence of EGTA at the 1:20
   trypsin/ι-carrageenase ratio indicate that the calcium binding sites
   were at least partly occupied in the protein, suggesting that they have
   a high affinity for calcium. Taken together, these findings demonstrate
   that calcium is involved in maintaining the structural integrity of the
   protein.
   [102]Figure 4
   View larger version:
     * [103]In this window
     * [104]In a new window

     * [105]Download as PowerPoint Slide

   Figure 4

   Protection of A. fortisι-carrageenase from trypsin hydrolysis by
   calcium binding. Proteins were separated by SDS-polyacrylamide gel
   electrophoresis on a 15% polyacrylamide gel and detected by Coomassie
   Blue staining. The number on the left indicates the size of the
   molecular mass markers in kDa (Amersham Pharmacia Biotech), while the
   band corresponding to trypsin is indicated on the right. Lane 1,
   ι-carrageenase (4 μg) in the absence of trypsin; lanes 2–4,
   trypsin/ι-carrageenase ratio of 1:100 (w/w); lanes 5–7,
   trypsin/ι-carrageenase ratio of 1:20 (w/w). Lanes 2 and5, hydrolysis in
   control buffer (100 mmTris-HCl, pH 7.2, 200 mm NaCl); lanes 3 and6,
   hydrolysis in the presence of 5 mm EGTA;lanes 4 and 7, hydrolysis in
   the presence of 5 mm CaCl[2].
   [106]Previous Section[107]Next Section

 §2§ DISCUSSION §2§

 §5§ Comparison of ι-Carrageenases with Other Right-handed Parallel β-Helix
Proteins §5§

   Only 11 protein structures are known to contain a right-handed parallel
   β-helix fold. Most are pectin-degrading enzymes and use a mechanism
   involving either β-elimination, e.g. the pectate and pectin lyases of
   family 1 of the polysaccharide lyases ([108]30, [109]35, [110]36), or
   acid/base hydrolysis, e.g. Aspergillus nigerrhamnogalacturonase
   ([111]37) and polygalacturonase ([112]38) as well asErwinia carotovora
   polygalacturonase ([113]39), which constitute family 28 of the
   glycoside hydrolases. Other right-handed parallel β-helix
   fold-containing proteins include chondroitin lyase B fromF. heparinum
   ([114]33), a virulence factor (P69 pertactin) from the whooping cough
   agent, the bacterium Bordetella pertussis([115]40), the tailspike
   rhamnosidase from phage P22 ([116]41), and a pectin methylesterase from
   E. chrysanthemi ([117]42). It is worth noting thus that most β-helix
   proteins (pectate lyases, rhamnogalacturonases, polygalacturonases,
   chondroitin lyases, and ι-carrageenases) are enzymes involved in the
   depolymerization of acidic polysaccharides with high linear charge
   densities from the extracellular matrix of plants or animals. The
   exceptions include pectin lyases, which can degrade the methylated form
   of polygalacturonic acid, the P22 tailspike protein, an
   endorhamnosidase involved in the recognition and degradation of the
   neutral, rhamnose-rich oligosaccharides known as O-antigen receptors
   ([118]43), and P69 pertactin, the specificity of which is unclear.

   Although ι-carrageenase does not share sequence similarity with family
   28 pectin hydrolases, its overall structure shows similarities with the
   family 28 fold. As in these rhamnogalacturonase and polygalacturonases,
   the ι-carrageenase β-helix fold consists of four parallel β-sheets. All
   three of these glycoside hydrolases proceed with an inversion of the
   anomeric configuration of their substrates. However, the
   pectin-degrading enzymes cleave α(1→4) or α(1→2) glycosidic bonds,
   whereas ι-carrageenase cleaves β(1→4) glycosidic linkages. It also
   appears that the family 28 pectinase catalytic residues Asp^180,
   Asp^201, and Asp^202 ([119]38, [120]44) are not structurally conserved
   in ι-carrageenase. We thus conclude that ι-carrageenases represent a
   genuinely new family of glycoside hydrolases referred to as family 82
   (13). Hence, although families 28 and 82 display the same protein fold,
   they act on different types of glycosidic bonds (α versusβ) and display
   different catalytic amino acids, and therefore they do not belong to
   the same clan of glycoside hydrolases ([121]14).

 §5§ Structure of the Putative Active Site and Recognition of ι-Carrageenan
Chains §5§

   ι-Carrageenase hydrolyzes glycosidic bonds with a mechanism leading to
   overall inversion of the anomeric configuration at the site of cleavage
   ([122]13). In such an inverting hydrolytic mechanism, the glycosidic
   bond is protonated by the acid/base catalyst to facilitate aglycon
   departure. This protonation step occurs concomitantly with the attack
   on the anomeric carbon by a water molecule activated by a base residue,
   yielding a product with an anomeric stereochemistry opposite to that of
   the substrate ([123]45, [124]46). In inverting glycoside hydrolases,
   the acid/base and nucleophile catalysts consist of aspartate and/or
   glutamate residues, their carboxyl groups being typically 10 Å apart
   ([125]47). However, family 28 pectinases feature an active site
   topology with a short distance (5–6 Å) between the catalytic residues
   ([126]38, [127]44).

   In the structure of E. chrysanthemi pectate lyase C complexed with a
   plant cell wall fragment, the oligosaccharide is found on PB1, defining
   the groove as the substrate binding site ([128]48). As discussed below,
   the groove in ι-carrageenase also appears to be the binding site for
   the ι-carrageenan chain. Of the acidic residues located in this cleft,
   only three, Glu^245, Asp^247, and Glu^310, are conserved between the
   two ι-carrageenase sequences. Glu^245 and Asp^247 are located at the
   bottom of the groove between domains A and B, and their carboxyl groups
   are separated by a distance of 4–5 Å. Glu^310 belongs to domain A, and
   its carboxyl group, which points toward the cleft, is separated by a
   distance of about 10 Å from the carboxyl groups of Glu^245 and Asp^247
   (Fig. [129]5). According to the DSSP program, Glu^245, Asp^247, and
   Glu^310 are all accessible to the solvent with respective accessible
   surface values of 31, 46, and 61 Å^2. Interestingly the entire region
   near these residues is well conserved in ι-carrageenases, and we
   propose that the nucleophile and acid/base catalysts are a yet to be
   determined pair among these three acidic amino acids.
   [130]Figure 5
   View larger version:
     * [131]In this window
     * [132]In a new window

     * [133]Download as PowerPoint Slide

   Figure 5

   Stereo view of the potential active site ofA. fortis ι-carrageenase.
   The conserved residues of ι-carrageenase are shown in red,blue, and
   black for oxygen, nitrogen, and carbon atoms, respectively. The other
   residues are shown in ribbon representation. The violet sphere
   represents a chloride ion. Residues Glu^245, Asp^247, and Glu^310are
   the potential catalytic amino acids, whereas His^281 may maintain the
   correct pK [a] of Glu^245. The basic residues Arg^243, Arg^303, and
   Arg^353 are probably involved in ι-carrageenan recognition.

   The catalytic cleft of ι-carrageenase is not large enough to correctly
   accommodate the double-stranded helix of ι-carrageenan for productive
   binding. Therefore, ι-carrageenase presumably initiates its action on
   single-stranded chains of the amorphous zones of ι-carrageenan gels. In
   κ-carrageenan, the glycosidic backbone contains alternating negatively
   charged units ofd-galactose-4-sulfate and hydrophobic
   3,6-anhydro-d-galactose residues. Consistent with these observations,
   the binding of κ-carrageenan by Pseudoalteromonas carrageenovora
   κ-carrageenase has been shown to involve both ionic interactions with
   sulfate-ester substituents and a specific hydrophobic environment for
   the 3,6-anhydro-d-galactose units ([134]16). Since ι-carrageenan bears
   a sulfate group at C-2 of the 3,6-anhydro-d-galactose moiety, this
   α(1→4)-linked residue is less hydrophobic than in the κ-carrageenans,
   and substrate binding by ι-carrageenases should mainly involve ionic
   interactions. This assumption is confirmed by the paucity, in the
   active site cleft of ι-carrageenase, of aromatic residues, which are
   known to interact with neutral saccharides through aromatic
   ring-pyranose ring stacking. The ι-carrageenase groove contains no
   tryptophan residues and only three tyrosine residues, Tyr^218, Tyr^224,
   and Tyr^400. In contrast, four arginine residues (Arg^125, Arg^243,
   Arg^303, and Arg^353) and one lysine residue (Lys^122), which are also
   present in Z. galactanovorans ι-carrageenase, point toward the cleft.
   Fig.[135]6 A shows the mapping of these conserved basic residues and of
   the catalytic residues on the surface of ι-carrageenase.
   [136]Figure 6
   View larger version:
     * [137]In this window
     * [138]In a new window

     * [139]Download as PowerPoint Slide

   Figure 6

   ι-Carrageenan recognition by ι-carrageenase. A, view of the molecular
   surface of the ι-carrageenase groove. The potential catalytic residues
   and the conserved basic amino acids are shown inred and blue,
   respectively. The distances between clusters of basic residues are
   shown. Fig. [140]6 was created using Grasp ([141]51). B, ball and stick
   representation of a ι-neocarrahexaose-sulfate ([142]7). Oxygen, sulfur,
   and carbon atoms are shown in red, yellow, and black, respectively.
   Distances between the sulfate substituents are shown.

   Based on the three-dimensional structure of the ι-carrageenan double
   helix ([143]7), the distribution of sulfate substituents along the
   ι-carrageenan chain is not homogeneous. Within the same repeating unit,
   the sulfate groups flank the α(1→3) glycosidic bond and are separated
   only by 4.65 Å. The distance between two such successive sulfate pairs
   is 11.5 Å, leaving the immediate vicinity of the β(1→4) linkages devoid
   of negative charges. Finally, two neighboring pairs of sulfate-ester
   substituents on the same side of the glycosidic backbone are separated
   by 16 Å (Fig. [144]6 B). This topology of the sulfate substituents on
   ι-carrageenan shows a striking match with the distribution of the
   conserved basic amino acids in the ι-carrageenase groove (Fig. [145]6
   A). Residues Arg^243 and Arg^303, separated by 7 Å, could form salt
   bridges with one ester-sulfate pair; this would position the uncleaved
   α(1→3) linkage between these two arginine residues and place the β(1→4)
   linkage to be cleaved next to the potential catalytic residues Glu^245,
   Asp^247, and Glu^310. This assumption is supported by the fact that
   Arg^243 and Arg^303 are tightly hydrogen-bonded to Glu^245 and Asp^305,
   respectively (Fig. [146]5). However, we do not know whether Arg^243
   interacts withd-galactose-4-sulfate and Arg^303 interacts with
   3,6-anhydro-d-galactose-2-sulfate or vice versa. Thus, Arg^243 and
   Arg^303 participate either in subsites −1 and −2 or subsites +1 and +2,
   and the directionality of the carbohydrate polymer chain with respect
   to the protein structure remains to be identified. Two other basic
   amino acids in the groove, Lys^122 and Arg^125, located 16 Å from
   Arg^243 (Fig. [147]6 A), are in the correct topology to bind the
   sulfate pair. Finally, the last basic residue, Arg^353, is 10 Å from
   Arg^303, again in a correct position to establish a salt bridge with
   the sulfate-ester substituent located 11.5 Å from the sulfate-ester
   bound to Arg^303.
   [148]Previous Section[149]Next Section

 §2§ ACKNOWLEDGEMENTS §2§

   We thank Dr. Ed Mitchell for invaluable help with the beamline ID14EH2
   (ESRF), Dr. Thierry Vernet for support with the Se-Met-substituted
   protein expression, Dr. Anne-Marie DiGuilmi for precious help with the
   proteolysis analysis, and Dr. Tristan Barbeyron for helpful discussion.
   [150]Previous Section[151]Next Section

 §2§ Footnotes §2§

     * [152]↵* This work was supported by grants from the Action Concertée
       Coordonnée Sciences du Vivant (No. V) and Groupement de Rechereches
       1002 of CNRS “Biology, Biochemistry and Genetics of Marine
       Algae.”The costs of publication of this article were defrayed in
       part by the payment of page charges. The article must therefore be
       hereby marked “advertisement” in accordance with 18 U.S.C. Section
       1734 solely to indicate this fact.
       The atomic coordinates and the structure factors (code ) have been
       deposited in the Protein Data Bank, Research Collaboratory for
       Structural Bioinformatics, Rutgers University, New Brunswick, NJ
       ([153]http://www.rcsb.org/).
     * [154]↵‖ To whom correspondence should be addressed. Tel.:
       33-4-38-78-56-09; Fax: 33-4-38-78-54-94; E-mail: otto@ibs.fr.
     * Published, JBC Papers in Press, August 7, 2001, DOI
       10.1074/jbc.M100670200
     * Abbreviations:

        Se-Met
                seleno-l-methionine

     *
          + Received January 24, 2001.
          + Revision received June 13, 2001.
     * The American Society for Biochemistry and Molecular Biology, Inc.

   [155]Previous Section

 §2§ REFERENCES §2§

    1. [156]↵
         1. Kloareg B.,
         2. Quatrano R. S.
       (1988) Oceanogr. Mar. Biol. Annu. Rev. 26:259–315.
    2. [157]↵
         1. Potin P.,
         2. Bouarab K.,
         3. Kupper F.,
         4. Kloareg B.
       (1999) Curr. Opin. Microbiol. 2:276–283.
       [158]CrossRef[159]Medline[160]Web of Science
    3. [161]↵
         1. Rees D. A.
       (1969) Adv. Carbohydr. Chem. Biochem. 24:267–332.
       [162]Medline
    4. [163]↵
         1. Morris E. R.,
         2. Rees D. A.,
         3. Robinson G.
       (1980) J. Mol. Biol. 138:349–362.
       [164]CrossRef[165]Medline[166]Web of Science
    5. [167]↵
         1. Viebke C.,
         2. Piculell L.,
         3. Nilsson S.
       (1994) Macromolecules 27:4160–4166.
       [168]CrossRef
    6. [169]↵
         1. Nishinari K.,
         2. Doi E.
         1. Piculell L.,
         2. Svante N.,
         3. Viebke C.,
         4. Zhang W.
       (1994) in Food Hydrocolloids: Structures, Properties and Functions,
       eds Nishinari K., Doi E. (Plenum Press, New York), pp 35–44.
    7. [170]↵
         1. Arnott S.,
         2. Scott W. E.,
         3. Rees D. A.,
         4. McNab C. G.
       (1974) J. Mol. Biol. 90:253–267.
       [171]CrossRef[172]Medline
    8. [173]↵
         1. Gordon-Mills E. M.,
         2. McCandless E. L.
       (1977) Phycologia 17:95–104.
    9. [174]↵
         1. Zablackis E.,
         2. Vreeland V.,
         3. Doboszewski B.,
         4. Laetsch W. M.
       (1991) J. Phycol. 27:241–248.
       [175]CrossRef[176]Web of Science
   10. [177]↵
       Johnston, K. H., and McCandless, E. L. (1973) Can. J. Microbiol.
       779–788.
   11. [178]↵
         1. Barbeyron T.,
         2. Henrissat B.,
         3. Kloareg B.
       (1994) Gene (Amst.) 139:105–109.
       [179]CrossRef[180]Medline
   12. [181]↵
         1. Barbeyron T.,
         2. Gerard A.,
         3. Potin P.,
         4. Henrissat B.,
         5. Kloareg B.
       (1998) Mol. Biol. Evol. 15:528–537.
       [182]Abstract
   13. [183]↵
         1. Barbeyron T.,
         2. Michel G.,
         3. Potin P.,
         4. Henrissat B.,
         5. Kloareg B.
       (2000) J. Biol. Chem. 275:35499–35505.
       [184]Abstract/FREE Full Text
   14. [185]↵
         1. Henrissat B.,
         2. Davies G.
       (1997) Curr. Opin. Struct. Biol. 7:637–644.
       [186]CrossRef[187]Medline[188]Web of Science
   15. [189]↵
         1. Michel G.,
         2. Flament D.,
         3. Barbeyron T.,
         4. Vernet T.,
         5. Kloareg B.,
         6. Dideberg O.
       (2000) Acta Crystallogr. Sect. D Biol. Crystallogr. 56:766–768.
       [190]CrossRef[191]Medline
   16. [192]↵
         1. Michel G.,
         2. Chantalat L.,
         3. Duée E.,
         4. Barbeyron T.,
         5. Henrissat B.,
         6. Kloareg B.,
         7. Dideberg O.
       (2001) Structure 9:513–525.
       [193]Medline
   17. [194]↵
         1. Maignan S.,
         2. Guilloteau J. P.,
         3. Zhou-Liu Q.,
         4. Clement-Mella C.,
         5. Mikol V.
       (1998) J. Mol. Biol. 282:359–368.
       [195]CrossRef[196]Medline[197]Web of Science
   18. [198]↵
         1. Otwinowski Z.,
         2. Minor W.
       (1997) Methods Enzymol. 276:307–326.
       [199]CrossRef[200]Web of Science
   19.
         1. Sheldrick G. M.
       (1997) Methods Enzymol. 276:628–641.
       [201]CrossRef[202]Web of Science
   20. [203]↵
         1. de La Fortelle E.,
         2. Bricogne G.
       (1997) Methods Enzymol. 276:472–494.
       [204]CrossRef[205]Web of Science
   21. [206]↵
         1. Collaborative Computational Project No. 4
       (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50:760–763.
       [207]CrossRef[208]Medline
   22. [209]↵
         1. Perrakis A.,
         2. Sixma T. K.,
         3. Wilson K. S.,
         4. Lamzin V. S.
       (1997) Acta Crystallogr. Sect. D Biol. Crystallogr. 53:448–455.
       [210]CrossRef[211]Medline
   23. [212]↵
         1. Jones T. A.,
         2. Zou J.-Y.,
         3. Cowan S. W.,
         4. Kjeldgaard M.
       (1991) Acta Crystallogr. Sect. A 47:110–119.
   24. [213]↵
         1. Brünger A. T.,
         2. Adams P. D.,
         3. Clore G. M.,
         4. DeLano W. L.,
         5. Gros P.,
         6. Grosse-Kunstleve R. W.,
         7. Jiang J. S.,
         8. Kuszewski J.,
         9. Nilges M.,
        10. Pannu N. S.,
        11. Read R. J.,
        12. Rice L. M.,
        13. Simonson T.,
        14. Warren G. L.
       (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54:905–921.
       [214]CrossRef[215]Medline
   25. [216]↵
         1. Brünger A. T.
       (1992) Nature 355:472–475.
       [217]CrossRef[218]Medline
   26. [219]↵
         1. Laskowski R. A.,
         2. MacArthur M. W.,
         3. Moss D. S.,
         4. Thornton J. M.
       (1993) J. Appl. Crystallogr. 26:283–291.
       [220]CrossRef
   27. [221]↵
         1. Kidby D. K.,
         2. Davidson D. J.
       (1973) Anal. Biochem. 55:321–325.
       [222]CrossRef[223]Medline[224]Web of Science
   28. [225]↵
         1. Hendrickson W. A.,
         2. Horton J. R.,
         3. LeMaster D. M.
       (1990) EMBO J. 9:1665–1672.
       [226]Medline[227]Web of Science
   29. [228]↵
         1. Ravelli R. B.,
         2. McSweeney S. M.
       (2000) Struct. Fold Des. 8:315–328.
       [229]Medline
   30. [230]↵
         1. Yoder M. D.,
         2. Keen N. T.,
         3. Jurnak F.
       (1993) Science 260:1503–1507.
       [231]Abstract/FREE Full Text
   31. [232]↵
         1. Kabsch W.,
         2. Sander C.
       (1983) Biopolymers 22:2577–2637.
       [233]CrossRef[234]Medline[235]Web of Science
   32. [236]↵
         1. Yoder M. D.,
         2. Lietzke S. E.,
         3. Jurnak F.
       (1993) Structure 1:241–251.
       [237]Medline
   33. [238]↵
         1. Huang W.,
         2. Matte A.,
         3. Li Y.,
         4. Kim Y. S.,
         5. Linhardt R. J.,
         6. Su H.,
         7. Cygler M.
       (1999) J. Mol. Biol. 294:1257–1269.
       [239]CrossRef[240]Medline[241]Web of Science
   34. [242]↵
         1. Greer C. W.,
         2. Yaphe W.
       (1984) Can. J. Microbiol. 30:1500–1506.
   35. [243]↵
         1. Pickersgill R.,
         2. Jenkins J.,
         3. Harris G.,
         4. Nasser W.,
         5. Robert-Baudouy J.
       (1994) Nat. Struct. Biol. 1:717–723.
       [244]CrossRef[245]Medline[246]Web of Science
   36. [247]↵
         1. Mayans O.,
         2. Scott M.,
         3. Connerton I.,
         4. Gravesen T.,
         5. Benen J.,
         6. Visser J.,
         7. Pickersgill R.,
         8. Jenkins J.
       (1997) Structure 5:677–689.
       [248]Medline
   37. [249]↵
         1. Petersen T. N.,
         2. Kauppinen S.,
         3. Larsen S.
       (1997) Structure 5:533–544.
       [250]Medline
   38. [251]↵
         1. van Santen Y.,
         2. Benen J. A.,
         3. Schroter K. H.,
         4. Kalk K. H.,
         5. Armand S.,
         6. Visser J.,
         7. Dijkstra B. W.
       (1999) J. Biol. Chem. 274:30474–30480.
       [252]Abstract/FREE Full Text
   39. [253]↵
         1. Pickersgill R.,
         2. Smith D.,
         3. Worboys K.,
         4. Jenkins J.
       (1998) J. Biol. Chem. 273:24660–24664.
       [254]Abstract/FREE Full Text
   40. [255]↵
         1. Emsley P.,
         2. Charles I. G.,
         3. Fairweather N. F.,
         4. Isaacs N. W.
       (1996) Nature 381:90–92.
       [256]CrossRef[257]Medline
   41. [258]↵
         1. Steinbacher S.,
         2. Seckler R.,
         3. Miller S.,
         4. Steipe B.,
         5. Huber R.,
         6. Reinemer P.
       (1994) Science 265:383–386.
       [259]Abstract/FREE Full Text
   42. [260]↵
         1. Jenkins J.,
         2. Mayans O.,
         3. Smith D.,
         4. Worboys K.,
         5. Pickersgill R. W.
       (2001) J. Mol. Biol. 305:951–960.
       [261]CrossRef[262]Medline[263]Web of Science
   43. [264]↵
         1. Steinbacher S.,
         2. Baxa U.,
         3. Miller S.,
         4. Weintraub A.,
         5. Seckler R.,
         6. Huber R.
       (1996) Proc. Natl. Acad. Sci. U. S. A. 93:10584–10588.
       [265]Abstract/FREE Full Text
   44. [266]↵
         1. Armand S.,
         2. Wagemaker M. J.,
         3. Sanchez-Torres P.,
         4. Kester H. C.,
         5. van Santen Y.,
         6. Dijkstra B. W.,
         7. Visser J.,
         8. Benen J. A.
       (2000) J. Biol. Chem. 275:691–696.
       [267]Abstract/FREE Full Text
   45. [268]↵
         1. Koshland D. E.
       (1953) Biol. Rev. Camb. Philos. Soc. 28:416–436.
       [269]CrossRef
   46. [270]↵
         1. Sinnott M. L.
       (1990) Chem. Rev. 90:1171–1202.
       [271]CrossRef[272]Web of Science
   47. [273]↵
         1. Davies G.,
         2. Henrissat B.
       (1995) Structure 3:853–859.
       [274]Medline
   48. [275]↵
         1. Scavetta R. D.,
         2. Herron S. R.,
         3. Hotchkiss A. T.,
         4. Kita N.,
         5. Keen N. T.,
         6. Benen J. A.,
         7. Kester H. C.,
         8. Visser J.,
         9. Jurnak F.
       (1999) Plant Cell 11:1081–1092.
       [276]Abstract/FREE Full Text
   49. [277]↵
         1. Davies G. J.,
         2. Wilson K. S.,
         3. Henrissat B.
       (1997) Biochem. J. 321:557–559.
   50. [278]↵
         1. Kraulis P. J.
       (1991) J. Appl. Crystallogr. 24:946–950.
       [279]CrossRef
   51. [280]↵
         1. Nicholls A.
       (1992) GRASP: Graphical Representation and Analysis of Surface
       Properties (Columbia University, New York).

     * [281]Add to CiteULike CiteULike
     * [282]Add to Complore Complore
     * [283]Add to Connotea Connotea
     * [284]Add to Del.icio.us Del.icio.us
     * [285]Add to Digg Digg

   [286]What's this?
   [287]« Previous | [288]Next Article »[289]Table of Contents

 §3§ This Article §3§

    1. First Published on August 7, 2001, doi: 10.1074/jbc.M100670200
       October 26, 2001 The Journal of Biological Chemistry, 276,
       40202-40209.

    1. [290]AbstractFree
    2. » Full TextFree
    3. [291]Full Text (PDF)Free
    4. All Versions of this Article:
         1. [292]M100670200v1
         2. 276/43/40202 most recent

 §4§ Classifications §4§

    1.
          + [293]PROTEIN STRUCTURE AND FOLDING

 §4§ Services §4§

    1. [294]Email this article to a friend
    2. [295]Alert me when this article is cited
    3. [296]Alert me if a correction is posted
    4. [297]Alert me when eletters are published
    5. [298]Similar articles in this journal
    6. [299]Similar articles in Web of Science
    7. [300]Similar articles in PubMed
    8. [301]Download to citation manager
    9. [302]Request Permissions

 §4§ Responses §4§

    1. [303]Submit a Letter to the Editor

 §4§ Citing Articles §4§

    1. [304]Load citing article information
    2. [305]Citing articles via Web of Science
    3. [306]Citing articles via Google Scholar

 §4§ Google Scholar §4§

    1. [307]Articles by Michel, G.
    2. [308]Articles by Dideberg, O.
    3. [309]Search for related content

 §4§ PubMed §4§

    1. [310]PubMed citation
    2. [311]Articles by Michel, G.
    3. [312]Articles by Dideberg, O.
    4.

 §4§ Related Content §4§

    1. [313]Load related web page information

 §4§ Social Bookmarking §4§

    1.
          + [314]Add to CiteULike CiteULike
          + [315]Add to Complore Complore
          + [316]Add to Connotea Connotea
          + [317]Add to Del.icio.us Del.icio.us
          + [318]Add to Digg Digg
       [319]What's this?

 §3§ Navigate This Article §3§

    1. [320]Top
    2. [321]Abstract
    3. [322]EXPERIMENTAL PROCEDURES
    4. [323]RESULTS
    5. [324]DISCUSSION
    6. [325]ACKNOWLEDGEMENTS
    7. [326]Footnotes
    8. [327]REFERENCES

 §3§ This Week's Issue §3§

    1. [328]September 24, 2010, 285 (39)

    1. [329]Current Issue

    1. [330]Alert me to new issues of JBC

     * [331]Authors
     * [332]Submit
     * [333]Subscribers
     * [334]Editorial Board
     * [335]RSS and Email Alerts
     * [336]Article Statistics
     * [337]Teaching Tools
     * [338]Copyright Permissions
     * [339]Advertise
     * [340]Contact JBC

     * Advertisement
     * Advertisement

   Copyright © 2010 by [341]American Society for Biochemistry and
   Molecular Biology

   [342]Alternate route to the JBC: http://intl.jbc.org

   [343]Contact JBC | [344]Help Pages
     * [345]asbmb_today_logo
     * [346]jlr_logo
     * [347]mcp_logo

     * Print ISSN 0021-9258
     * Online ISSN 1083-351X

   Advertisement
   Advertisement
     * [348]Cytochrome P450: Special JBC Thematic Series. Read Free
       Articles!

References

   Visible links
   1. http://www.jbc.org/
   2. file://localhost/dev/paper.html#content-block
   3. http://www.jbc.org/
   4. http://www.jbc.org/content/current
   5. http://www.jbc.org/content/by/year
   6. http://www.jbc.org/content/early/recent/0
   7. http://www.jbc.org/content/by/section/Minireviews
   8. http://www.jbc.org/content/by/section/Classics
   9. http://www.jbc.org/content/by/section/Reflections
  10. http://www.jbc.org/potw
  11. http://www.jbc.org/search
  12. http://www.jbc.org/content/by/year
  13. http://www.jbc.org/login?uri=http%3A%2F%2Fwww.jbc.org%2Fcontent%2F276%2F43%2F40202.long
  14. http://www.jbc.org/cgi/adclick/?ad=21396&adclick=true&url=http%3A%2F%2Fwww.asbmb.org%2FPage.aspx%3Fid%3D3362
  15. file://localhost/dev/paper.html#fn-6
  16. http://www.jbc.org/search?author1=Gurvan+Michel&sortspec=date&submit=Submit
  17. file://localhost/dev/paper.html#target-1
  18. file://localhost/dev/paper.html#target-2
  19. http://www.jbc.org/search?author1=Laurent+Chantalat&sortspec=date&submit=Submit
  20. file://localhost/dev/paper.html#target-1
  21. http://www.jbc.org/search?author1=Eric+Fanchon&sortspec=date&submit=Submit
  22. file://localhost/dev/paper.html#target-1
  23. http://www.jbc.org/search?author1=Bernard+Henrissat&sortspec=date&submit=Submit
  24. file://localhost/dev/paper.html#target-3
  25. http://www.jbc.org/search?author1=Bernard+Kloareg&sortspec=date&submit=Submit
  26. file://localhost/dev/paper.html#target-2
  27. http://www.jbc.org/search?author1=Otto+Dideberg&sortspec=date&submit=Submit
  28. file://localhost/dev/paper.html#target-1
  29. file://localhost/dev/paper.html#fn-7
  30. file://localhost/dev/paper.html#sec-1
  31. file://localhost/dev/paper.html#ref-1
  32. file://localhost/dev/paper.html#ref-2
  33. file://localhost/dev/paper.html#F1
  34. file://localhost/dev/paper.html#ref-1
  35. http://www.jbc.org/content/276/43/40202/F1.expansion.html
  36. http://www.jbc.org/content/276/43/40202/F1.expansion.html
  37. http://www.jbc.org/content/276/43/40202/F1.expansion.html
  38. http://www.jbc.org/powerpoint/276/43/40202/F1
  39. file://localhost/dev/paper.html#ref-49
  40. file://localhost/dev/paper.html#ref-3
  41. file://localhost/dev/paper.html#ref-4
  42. file://localhost/dev/paper.html#ref-5
  43. file://localhost/dev/paper.html#ref-6
  44. file://localhost/dev/paper.html#ref-7
  45. file://localhost/dev/paper.html#ref-7
  46. file://localhost/dev/paper.html#ref-8
  47. file://localhost/dev/paper.html#ref-9
  48. file://localhost/dev/paper.html#ref-10
  49. file://localhost/dev/paper.html#ref-14
  50. file://localhost/dev/paper.html#ref-15
  51. file://localhost/dev/paper.html#abstract-1
  52. file://localhost/dev/paper.html#sec-8
  53. file://localhost/dev/paper.html#ref-15
  54. http://www.jbc.org/cgi/redirect-inline?ad=Novagen
  55. file://localhost/dev/paper.html#ref-16
  56. file://localhost/dev/paper.html#ref-15
  57. file://localhost/dev/paper.html#ref-17
  58. file://localhost/dev/paper.html#ref-18
  59. file://localhost/dev/paper.html#ref-20
  60. file://localhost/dev/paper.html#ref-18
  61. file://localhost/dev/paper.html#ref-21
  62. file://localhost/dev/paper.html#ref-21
  63. file://localhost/dev/paper.html#ref-22
  64. file://localhost/dev/paper.html#ref-23
  65. file://localhost/dev/paper.html#ref-24
  66. file://localhost/dev/paper.html#ref-25
  67. file://localhost/dev/paper.html#ref-26
  68. file://localhost/dev/paper.html#ref-27
  69. file://localhost/dev/paper.html#sec-1
  70. file://localhost/dev/paper.html#sec-13
  71. file://localhost/dev/paper.html#ref-28
  72. file://localhost/dev/paper.html#F2
  73. file://localhost/dev/paper.html#T1
  74. file://localhost/dev/paper.html#ref-29
  75. http://www.jbc.org/content/276/43/40202/F2.expansion.html
  76. http://www.jbc.org/content/276/43/40202/F2.expansion.html
  77. http://www.jbc.org/content/276/43/40202/F2.expansion.html
  78. http://www.jbc.org/powerpoint/276/43/40202/F2
  79. file://localhost/dev/paper.html#ref-23
  80. http://www.jbc.org/content/276/43/40202/T1.expansion.html
  81. http://www.jbc.org/content/276/43/40202/T1.expansion.html
  82. file://localhost/dev/paper.html#F3
  83. file://localhost/dev/paper.html#ref-30
  84. file://localhost/dev/paper.html#ref-31
  85. http://www.jbc.org/content/276/43/40202/F3.expansion.html
  86. http://www.jbc.org/content/276/43/40202/F3.expansion.html
  87. http://www.jbc.org/content/276/43/40202/F3.expansion.html
  88. http://www.jbc.org/powerpoint/276/43/40202/F3
  89. file://localhost/dev/paper.html#F3
  90. file://localhost/dev/paper.html#F4
  91. file://localhost/dev/paper.html#ref-50
  92. file://localhost/dev/paper.html#F3
  93. file://localhost/dev/paper.html#F3
  94. file://localhost/dev/paper.html#ref-15
  95. file://localhost/dev/paper.html#ref-32
  96. file://localhost/dev/paper.html#ref-33
  97. file://localhost/dev/paper.html#ref-13
  98. file://localhost/dev/paper.html#ref-34
  99. file://localhost/dev/paper.html#ref-13
 100. file://localhost/dev/paper.html#F2
 101. file://localhost/dev/paper.html#F4
 102. http://www.jbc.org/content/276/43/40202/F4.expansion.html
 103. http://www.jbc.org/content/276/43/40202/F4.expansion.html
 104. http://www.jbc.org/content/276/43/40202/F4.expansion.html
 105. http://www.jbc.org/powerpoint/276/43/40202/F4
 106. file://localhost/dev/paper.html#sec-8
 107. file://localhost/dev/paper.html#ack-1
 108. file://localhost/dev/paper.html#ref-30
 109. file://localhost/dev/paper.html#ref-35
 110. file://localhost/dev/paper.html#ref-36
 111. file://localhost/dev/paper.html#ref-37
 112. file://localhost/dev/paper.html#ref-38
 113. file://localhost/dev/paper.html#ref-39
 114. file://localhost/dev/paper.html#ref-33
 115. file://localhost/dev/paper.html#ref-40
 116. file://localhost/dev/paper.html#ref-41
 117. file://localhost/dev/paper.html#ref-42
 118. file://localhost/dev/paper.html#ref-43
 119. file://localhost/dev/paper.html#ref-38
 120. file://localhost/dev/paper.html#ref-44
 121. file://localhost/dev/paper.html#ref-14
 122. file://localhost/dev/paper.html#ref-13
 123. file://localhost/dev/paper.html#ref-45
 124. file://localhost/dev/paper.html#ref-46
 125. file://localhost/dev/paper.html#ref-47
 126. file://localhost/dev/paper.html#ref-38
 127. file://localhost/dev/paper.html#ref-44
 128. file://localhost/dev/paper.html#ref-48
 129. file://localhost/dev/paper.html#F5
 130. http://www.jbc.org/content/276/43/40202/F5.expansion.html
 131. http://www.jbc.org/content/276/43/40202/F5.expansion.html
 132. http://www.jbc.org/content/276/43/40202/F5.expansion.html
 133. http://www.jbc.org/powerpoint/276/43/40202/F5
 134. file://localhost/dev/paper.html#ref-16
 135. file://localhost/dev/paper.html#F6
 136. http://www.jbc.org/content/276/43/40202/F6.expansion.html
 137. http://www.jbc.org/content/276/43/40202/F6.expansion.html
 138. http://www.jbc.org/content/276/43/40202/F6.expansion.html
 139. http://www.jbc.org/powerpoint/276/43/40202/F6
 140. file://localhost/dev/paper.html#F6
 141. file://localhost/dev/paper.html#ref-51
 142. file://localhost/dev/paper.html#ref-7
 143. file://localhost/dev/paper.html#ref-7
 144. file://localhost/dev/paper.html#F6
 145. file://localhost/dev/paper.html#F6
 146. file://localhost/dev/paper.html#F5
 147. file://localhost/dev/paper.html#F6
 148. file://localhost/dev/paper.html#sec-13
 149. file://localhost/dev/paper.html#fn-group-1
 150. file://localhost/dev/paper.html#ack-1
 151. file://localhost/dev/paper.html#ref-list-1
 152. file://localhost/dev/paper.html#xref-fn-6-1
 153. http://www.rcsb.org/
 154. file://localhost/dev/paper.html#xref-fn-7-1
 155. file://localhost/dev/paper.html#fn-group-1
 156. file://localhost/dev/paper.html#xref-ref-1-1
 157. file://localhost/dev/paper.html#xref-ref-2-1
 158. http://www.jbc.org/external-ref?access_num=10.1016/S1369-5274(99)80048-4&link_type=DOI
 159. http://www.jbc.org/external-ref?access_num=10383869&link_type=MED
 160. http://www.jbc.org/external-ref?access_num=000080853500009&link_type=ISI
 161. file://localhost/dev/paper.html#xref-ref-3-1
 162. http://www.jbc.org/external-ref?access_num=4913938&link_type=MED
 163. file://localhost/dev/paper.html#xref-ref-4-1
 164. http://www.jbc.org/external-ref?access_num=10.1016/0022-2836(80)90291-0&link_type=DOI
 165. http://www.jbc.org/external-ref?access_num=7411612&link_type=MED
 166. http://www.jbc.org/external-ref?access_num=A1980JN48100010&link_type=ISI
 167. file://localhost/dev/paper.html#xref-ref-5-1
 168. http://www.jbc.org/external-ref?access_num=10.1021/ma00093a017&link_type=DOI
 169. file://localhost/dev/paper.html#xref-ref-6-1
 170. file://localhost/dev/paper.html#xref-ref-7-1
 171. http://www.jbc.org/external-ref?access_num=10.1016/0022-2836(74)90371-4&link_type=DOI
 172. http://www.jbc.org/external-ref?access_num=4453016&link_type=MED
 173. file://localhost/dev/paper.html#xref-ref-8-1
 174. file://localhost/dev/paper.html#xref-ref-9-1
 175. http://www.jbc.org/external-ref?access_num=10.1111/j.0022-3646.1991.00241.x&link_type=DOI
 176. http://www.jbc.org/external-ref?access_num=A1991FH98300012&link_type=ISI
 177. file://localhost/dev/paper.html#xref-ref-10-1
 178. file://localhost/dev/paper.html#xref-ref-10-1
 179. http://www.jbc.org/external-ref?access_num=10.1016/0378-1119(94)90531-2&link_type=DOI
 180. http://www.jbc.org/external-ref?access_num=8112578&link_type=MED
 181. file://localhost/dev/paper.html#xref-ref-10-1
 182. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=molbiolevol&resid=15/5/528
 183. file://localhost/dev/paper.html#xref-ref-10-1
 184. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/45/35499
 185. file://localhost/dev/paper.html#xref-ref-14-1
 186. http://www.jbc.org/external-ref?access_num=10.1016/S0959-440X(97)80072-3&link_type=DOI
 187. http://www.jbc.org/external-ref?access_num=9345621&link_type=MED
 188. http://www.jbc.org/external-ref?access_num=A1997YB57900006&link_type=ISI
 189. file://localhost/dev/paper.html#xref-ref-15-1
 190. http://www.jbc.org/external-ref?access_num=10.1107/S0907444900004844&link_type=DOI
 191. http://www.jbc.org/external-ref?access_num=10818359&link_type=MED
 192. file://localhost/dev/paper.html#xref-ref-16-1
 193. http://www.jbc.org/external-ref?access_num=11435116&link_type=MED
 194. file://localhost/dev/paper.html#xref-ref-17-1
 195. http://www.jbc.org/external-ref?access_num=10.1006/jmbi.1998.2002&link_type=DOI
 196. http://www.jbc.org/external-ref?access_num=9735293&link_type=MED
 197. http://www.jbc.org/external-ref?access_num=000075907300013&link_type=ISI
 198. file://localhost/dev/paper.html#xref-ref-18-1
 199. http://www.jbc.org/external-ref?access_num=10.1016/S0076-6879(97)76066-X&link_type=DOI
 200. http://www.jbc.org/external-ref?access_num=A1997BH42P00020&link_type=ISI
 201. http://www.jbc.org/external-ref?access_num=10.1016/S0076-6879(97)76083-X&link_type=DOI
 202. http://www.jbc.org/external-ref?access_num=A1997BH42P00037&link_type=ISI
 203. file://localhost/dev/paper.html#xref-ref-20-1
 204. http://www.jbc.org/external-ref?access_num=10.1016/S0076-6879(97)76073-7&link_type=DOI
 205. http://www.jbc.org/external-ref?access_num=A1997BH42P00027&link_type=ISI
 206. file://localhost/dev/paper.html#xref-ref-21-1
 207. http://www.jbc.org/external-ref?access_num=10.1107/S0907444994003112&link_type=DOI
 208. http://www.jbc.org/external-ref?access_num=15299374&link_type=MED
 209. file://localhost/dev/paper.html#xref-ref-22-1
 210. http://www.jbc.org/external-ref?access_num=10.1107/S0907444997005696&link_type=DOI
 211. http://www.jbc.org/external-ref?access_num=15299911&link_type=MED
 212. file://localhost/dev/paper.html#xref-ref-23-1
 213. file://localhost/dev/paper.html#xref-ref-24-1
 214. http://www.jbc.org/external-ref?access_num=10.1107/S0907444998003254&link_type=DOI
 215. http://www.jbc.org/external-ref?access_num=9757107&link_type=MED
 216. file://localhost/dev/paper.html#xref-ref-25-1
 217. http://www.jbc.org/external-ref?access_num=10.1038/355472a0&link_type=DOI
 218. http://www.jbc.org/external-ref?access_num=18481394&link_type=MED
 219. file://localhost/dev/paper.html#xref-ref-26-1
 220. http://www.jbc.org/external-ref?access_num=10.1107/S0021889892009944&link_type=DOI
 221. file://localhost/dev/paper.html#xref-ref-27-1
 222. http://www.jbc.org/external-ref?access_num=10.1016/0003-2697(73)90323-0&link_type=DOI
 223. http://www.jbc.org/external-ref?access_num=4753157&link_type=MED
 224. http://www.jbc.org/external-ref?access_num=A1973Q619400039&link_type=ISI
 225. file://localhost/dev/paper.html#xref-ref-28-1
 226. http://www.jbc.org/external-ref?access_num=2184035&link_type=MED
 227. http://www.jbc.org/external-ref?access_num=A1990DB52700040&link_type=ISI
 228. file://localhost/dev/paper.html#xref-ref-29-1
 229. http://www.jbc.org/external-ref?access_num=10745008&link_type=MED
 230. file://localhost/dev/paper.html#xref-ref-30-1
 231. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=sci&resid=260/5113/1503
 232. file://localhost/dev/paper.html#xref-ref-31-1
 233. http://www.jbc.org/external-ref?access_num=10.1002/bip.360221211&link_type=DOI
 234. http://www.jbc.org/external-ref?access_num=6667333&link_type=MED
 235. http://www.jbc.org/external-ref?access_num=A1983RV60400010&link_type=ISI
 236. file://localhost/dev/paper.html#xref-ref-32-1
 237. http://www.jbc.org/external-ref?access_num=8081738&link_type=MED
 238. file://localhost/dev/paper.html#xref-ref-33-1
 239. http://www.jbc.org/external-ref?access_num=10.1006/jmbi.1999.3292&link_type=DOI
 240. http://www.jbc.org/external-ref?access_num=10600383&link_type=MED
 241. http://www.jbc.org/external-ref?access_num=000084596800018&link_type=ISI
 242. file://localhost/dev/paper.html#xref-ref-34-1
 243. file://localhost/dev/paper.html#xref-ref-35-1
 244. http://www.jbc.org/external-ref?access_num=10.1038/nsb1094-717&link_type=DOI
 245. http://www.jbc.org/external-ref?access_num=7634076&link_type=MED
 246. http://www.jbc.org/external-ref?access_num=A1994QN60600015&link_type=ISI
 247. file://localhost/dev/paper.html#xref-ref-36-1
 248. http://www.jbc.org/external-ref?access_num=9195887&link_type=MED
 249. file://localhost/dev/paper.html#xref-ref-37-1
 250. http://www.jbc.org/external-ref?access_num=9115442&link_type=MED
 251. file://localhost/dev/paper.html#xref-ref-38-1
 252. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=274/43/30474
 253. file://localhost/dev/paper.html#xref-ref-39-1
 254. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/38/24660
 255. file://localhost/dev/paper.html#xref-ref-40-1
 256. http://www.jbc.org/external-ref?access_num=10.1038/381090a0&link_type=DOI
 257. http://www.jbc.org/external-ref?access_num=8609998&link_type=MED
 258. file://localhost/dev/paper.html#xref-ref-41-1
 259. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=sci&resid=265/5170/383
 260. file://localhost/dev/paper.html#xref-ref-42-1
 261. http://www.jbc.org/external-ref?access_num=10.1006/jmbi.2000.4324&link_type=DOI
 262. http://www.jbc.org/external-ref?access_num=11162105&link_type=MED
 263. http://www.jbc.org/external-ref?access_num=000166748300024&link_type=ISI
 264. file://localhost/dev/paper.html#xref-ref-43-1
 265. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=93/20/10584
 266. file://localhost/dev/paper.html#xref-ref-44-1
 267. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/1/691
 268. file://localhost/dev/paper.html#xref-ref-45-1
 269. http://www.jbc.org/external-ref?access_num=10.1111/j.1469-185X.1953.tb01386.x&link_type=DOI
 270. file://localhost/dev/paper.html#xref-ref-46-1
 271. http://www.jbc.org/external-ref?access_num=10.1021/cr00105a006&link_type=DOI
 272. http://www.jbc.org/external-ref?access_num=A1990EH74200007&link_type=ISI
 273. file://localhost/dev/paper.html#xref-ref-47-1
 274. http://www.jbc.org/external-ref?access_num=8535779&link_type=MED
 275. file://localhost/dev/paper.html#xref-ref-48-1
 276. http://www.jbc.org/cgi/ijlink?linkType=ABST&journalCode=plantcell&resid=11/6/1081
 277. file://localhost/dev/paper.html#xref-ref-49-1
 278. file://localhost/dev/paper.html#xref-ref-50-1
 279. http://www.jbc.org/external-ref?access_num=10.1107/S0021889891004399&link_type=DOI
 280. file://localhost/dev/paper.html#xref-ref-51-1
 281. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=CITEULIKE
 282. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=COMPLORE
 283. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=CONNOTEA
 284. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=DEL_ICIO_US
 285. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=DIGG
 286. http://www.jbc.org/help/social_bookmarks.dtl
 287. http://www.jbc.org/content/276/43/40190.short
 288. http://www.jbc.org/content/276/43/40210.short
 289. http://www.jbc.org/content/276/43.toc
 290. http://www.jbc.org/content/276/43/40202.abstract
 291. http://www.jbc.org/content/276/43/40202.full.pdf+html
 292. http://www.jbc.org/content/early/2001/08/07/jbc.M100670200
 293. http://www.jbc.org/search?tocsectionid=PROTEIN+STRUCTURE+AND+FOLDING&sortspec=date&submit=Submit
 294. http://www.jbc.org/email?gca=jbc;276/43/40202&current-view-path=/content/276/43/40202.long
 295. http://www.jbc.org/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&cited_by_criteria_resid=jbc;276/43/40202&saveAlert=no&return-type=article&return_url=http://www.jbc.org/content/276/43/40202.long
 296. http://www.jbc.org/cgi/alerts/ctalert?alertType=correction&addAlert=correction&correction_criteria_value=276/43/40202&saveAlert=no&return-type=article&return_url=http://www.jbc.org/content/276/43/40202.long
 297. http://www.jbc.org/cgi/alerts/ctalert?alertType=eletter&addAlert=eletter&eletter_criteria_value=276/43/40202&saveAlert=no&return-type=article&return_url=http://www.jbc.org/content/276/43/40202.long
 298. http://www.jbc.org/search?qbe=jbc;M100670200&citation=Michel%20et%20al.%20276%20%2843%29:%2040202&submit=yes
 299. http://www.jbc.org/external-ref?access_num=jbc%3B276%2F43%2F40202&link_type=ISI_RELATEDRECORDS
 300. http://www.jbc.org/external-ref?access_num=11493601&link_type=MED_NBRS
 301. http://www.jbc.org/citmgr?gca=jbc;276/43/40202
 302. https://s100.copyright.com/AppDispatchServlet?publisherName=ASBMB&publication=jbc&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis:A%20%CE%B2-HELIX%20FOLD-CONTAINING%20ENZYME%20FOR%20THE%20DEGRADATION%20OF%20A%20HIGHLY%20POLYANIONIC%20POLYSACCHARIDE&publicationDate=10/26/2001&author=Gurvan%20Michel,%20Laurent%20Chantalat,%20Eric%20Fanchon,%20Bernard%20Henrissat,%20Bernard%20Kloareg,%20Otto%20Dideberg&startPage=40202&contentID=10.1074/jbc.M100670200&orderBeanReset=true&endPage=40209&volumeNum=276&issueNum=43
 303. http://www.jbc.org/letters/submit/jbc;276/43/40202
 304. http://www.jbc.org/content/276/43/40202.long?cited-by=yes&legid=jbc;276/43/40202#cited-by
 305. http://www.jbc.org/external-ref?access_num=jbc%3B276%2F43%2F40202&link_type=ISI_CITING
 306. http://www.jbc.org/external-ref?access_num=http://www.jbc.org/cgi/content/abstract/276/43/40202&link_type=GOOGLESCHOLAR
 307. http://scholar.google.com/scholar?q=%22author%3AMichel%20author%3AG.%22
 308. http://scholar.google.com/scholar?q=%22author%3ADideberg%20author%3AO.%22
 309. http://www.jbc.org/external-ref?access_num=http://www.jbc.org/cgi/content/abstract/276/43/40202&link_type=GOOGLESCHOLARRELATED
 310. http://www.jbc.org/external-ref?access_num=11493601&link_type=PUBMED
 311. http://www.jbc.org/external-ref?access_num=Michel%20G&link_type=AUTHORSEARCH
 312. http://www.jbc.org/external-ref?access_num=Dideberg%20O&link_type=AUTHORSEARCH
 313. http://www.jbc.org/content/276/43/40202.long?related-urls=yes&legid=jbc;276/43/40202#related-urls
 314. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=CITEULIKE
 315. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=COMPLORE
 316. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=CONNOTEA
 317. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=DEL_ICIO_US
 318. http://www.jbc.org/external-ref?tag_url=http://www.jbc.org/cgi/content/long/276/43/40202&title=The%20%CE%B9-Carrageenase%20of%20Alteromonas%20fortis+--+Michel%20et%20al.%20276%20%2843%29%3A%2040202+--+JBC&doi=10.1074/jbc.M100670200&link_type=DIGG
 319. http://www.jbc.org/help/social_bookmarks.dtl
 320. file://localhost/dev/paper.html#content-block
 321. file://localhost/dev/paper.html#abstract-1
 322. file://localhost/dev/paper.html#sec-1
 323. file://localhost/dev/paper.html#sec-8
 324. file://localhost/dev/paper.html#sec-13
 325. file://localhost/dev/paper.html#ack-1
 326. file://localhost/dev/paper.html#fn-group-1
 327. file://localhost/dev/paper.html#ref-list-1
 328. http://www.jbc.org/content/current
 329. http://www.jbc.org/content/current
 330. http://www.jbc.org/cgi/alerts/etoc
 331. http://www.jbc.org/misc/itoa.xhtml
 332. http://submit.jbc.org/
 333. http://www.jbc.org/subscriptions/
 334. http://submit.jbc.org/journals/jbc/forms/editors.dtl
 335. http://www.jbc.org/site/home/about/rss_alerts.xhtml
 336. http://www.jbc.org/site/home/about/article_stats.xhtml
 337. http://www.jbc.org/site/home/teaching_tools/
 338. http://www.jbc.org/site/misc/Copyright_Permission.xhtml
 339. http://www.asbmb.org/uploadedFiles/Publications/2009ASBMBJournalsMediaKit.pdf
 340. http://www.jbc.org/cgi/feedback
 341. http://www.asbmb.org/
 342. http://intl.jbc.org/
 343. http://www.jbc.org/cgi/feedback
 344. http://www.jbc.org/help/
 345. http://www.asbmb.org/page.aspx?id=218
 346. http://www.jlr.org/
 347. http://mcponline.org/
 348. http://www.jbc.org/cgi/adclick/?ad=21402&adclick=true&url=http%3A%2F%2Fwww.jbc.org%2Fsite%2Fcollections%2Fp450%2F

   Hidden links:
 349. http://www.jbc.org/entrez-links/11493601